Finance

Beta
Lists
ALZN:NASDAQ
Alzamend Neuro Inc
$1.15
-0.86%
(-0.0100) 1D
Jun 9, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALZN...
Open
$1.15
High
$1.16
Low
$1.12
Mkt. cap
4.38M
Avg. vol.
56.35K
Volume
0.00
52-wk high
$3.60
52-wk low
$0.85
EPS
-$4.59
Beta
0.16
Shares outstanding
3.80M
No. of employees
5
Open
$1.15
High
$1.16
Low
$1.12
Mkt. cap
4.38M
Avg. vol.
56.35K
Volume
0.00
52-wk high
$3.60
52-wk low
$0.85
EPS
-$4.59
Beta
0.16
Shares outstanding
3.80M
No. of employees
5
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to ALZN in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for ALZN in the last 3 months.
Highest
Current $1.15
$25.00 (+2,073.91%)
Average
$25.00 (+2,073.91%)
Lowest
$25.00 (+2,073.91%)
News stories
From sources across the web
About Alzamend Neuro Inc
CEO-
Employees5
Founded2016
HeadquartersAtlanta, Georgia, United States
SectorBiotechnology
Websitealzamend.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
450.16K
1.74M
176.28K
1.28M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
688.78K
959.33K
821.83K
919.02K
Operating expense
1.14M
2.70M
998.11K
2.20M
Total operating expenses
1.14M
2.70M
998.11K
2.20M
Operating income
-1.14M
-2.70M
-998.11K
-2.20M
Other non operating income
-
-
-
-
EBT including unusual items
-1.14M
-2.70M
-1.00M
-2.20M
EBT excluding unusual items
-1.14M
-2.70M
-1.00M
-2.20M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.14M
-2.70M
-1.00M
-2.20M
Net profit margin
-
-
-
-
Earnings per share
-9.48
-1.28
-0.30
-0.58
Interest and investment income
-
-
-
-
Interest expense
-509.00
-2.48K
-2.65K
-1.34K
Net interest expenses
-509.00
-2.48K
-2.65K
-1.34K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.13M
-2.67M
-970.42K
-2.17M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer